+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Construction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery System

Construction of Hyaluronic Tetrasaccharide Clusters Modified Polyamidoamine siRNA Delivery System

Nanomaterials 8(6):

The CD44 protein, as a predominant receptor for hyaluronan (HA), is highly expressed on the surface of multiple tumor cells. HA, as a targeting molecule for a CD44-contained delivery system, increases intracellular drug concentration in tumor tissue. However, due to the weak binding ability of hyaluronan oligosaccharide to CD44, targeting for tumor drug delivery has been restricted. In this study, we first use a HA tetrasaccharide cluster as the target ligand to enhance the binding ability to CD44. A polyamidoamine (PAMAM) dendrimer was modified by a HA tetrasaccharide cluster as a nonviral vector for small interfering RNA (siRNA) delivery. The dendrimer/siRNA nanocomplexes increased the cellular uptake capacity of siRNA through the CD44 receptor-mediated endocytosis pathway, allowing the siRNA to successfully escape the endosome/lysosome. Compared with the control group, nanocomplexes effectively reduced the expression of GFP protein and mRNA in MDA-MB-231-GFP cells. This delivery system provides a foundation to increase the clinical applications of PAMAM nanomaterials.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 056201739

Download citation: RISBibTeXText

PMID: 29899207

DOI: 10.3390/nano8060433

Related references

Efficient siRNA delivery using a polyamidoamine dendrimer with a modified pentaerythritol core. Pharmaceutical Research 29(6): 1627-1636, 2012

Surface-modified and internally cationic polyamidoamine dendrimers for efficient siRNA delivery. Bioconjugate Chemistry 19(7): 1396-1403, 2008

PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy. Journal of Pharmaceutical Sciences 104(2): 476-484, 2015

Modulated cellular delivery of anti-VEGF siRNA (bevasiranib) by incorporating supramolecular assemblies of hydrophobically modified polyamidoamine dendrimer in stealth liposomes. International Journal of Pharmaceutics 510(1): 30-41, 2016

Co-delivery of siRNA and hypericin into cancer cells by hyaluronic acid modified PLGA-PEI nanoparticles. Drug Development and Industrial Pharmacy 42(5): 737-746, 2016

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. International Journal of Pharmaceutics 414(1-2): 233-243, 2011

A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates HHSCs for efficient receptor- mediated siRNA delivery. 2011

Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery. Journal of Nanoscience and Nanotechnology 14(10): 7388-7394, 2014

Overcoming drug resistance of MCF-7/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. Journal of Controlled Release 163(2): 136-144, 2012

Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells. Oligonucleotides 19(2): 103-116, 2009

Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Biomaterials 35(25): 7121-7132, 2014

The AGMA1 polyamidoamine mediates the efficient delivery of siRNA. Journal of Drug Targeting 25(9-10): 891-898, 2017

Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells. Acta Biomaterialia 66: 294-309, 2018

Construction of an Aptamer-SiRNA Chimera-Modified Tissue-Engineered Blood Vessel for Cell-Type-Specific Capture and Delivery. Acs Nano 9(6): 6069-6076, 2015

Phenylboronic acid-functionalized polyamidoamine-mediated Bcl-2 siRNA delivery for inhibiting the cell proliferation. Colloids and Surfaces. B Biointerfaces 146: 318-325, 2016